Author:
Relling Mary V.,Evans Robert R.,Groom Steven,Crom William R.,Pratt Charles B.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Reference21 articles.
1. P. J. O'Dwyer, D. Shoemaker, D. S. Zaharko, C. Grieshaber, J. Plowman, T. Corbett, F. Valeriote, S. A. King, J. Cradock, D. F. Hoth, and B. Leyland-Jones. Flavone acetic acid (LM 975, NSC 347512): A novel antitumor agent.Cancer Chemother. Pharmacol. 19:6–10 (1987).
2. J. Cummings and J. F. Smyth. Flavone 8-acetic acid: Our current understanding of its mechanism of action in solid tumours.Cancer Chemother. and Pharmacol. 24:269–272 (1989).
3. C. B. Pratt, M. V. Relling, W. H. Meyer, E. C. Douglass, S. J. Kellie, and L. Avery. Phase I study of flavone acetic acid (NSC 347512, LM975) in patients with pediatric malignant solid tumors.Am. J. Clin. Oncol. 14:483–486 (1991).
4. R. B. Weiss, R. F. Green, R. D. Knight, J. M. Collins, J. J. Pelosi, A. Sulkes, and G. A. Curt. Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512).Cancer Res. 48:5878–5882 (1988).
5. D. J. Kerr, S. B. Kaye, J. Cassidy, C. Bradley, E. M. Rankin, L. Adams, A. Setanoians, T. Young, G. Forrest, M. Soukop, and M. Clavel. Phase I and pharmacokinetic study of flavone acetic acid.Cancer Res. 47:6776–6781 (1987).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献